David Fisher

Eng koʻp iqtibos qilingan asarlar

1. Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo20240 iqtibos
2. Clinical factors associated with invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: analysis of a 6-year clinical experience20240 iqtibos
3. Therapeutic potential of natural products in schistosomiasis-associated liver fibrosis20240 iqtibos
4. Cell Cycle-Related LncRNA-Based Prognostic Model for Hepatocellular Carcinoma: Integrating Immune Microenvironment and Treatment Response20240 iqtibos
5. The History of Controlling and Treating Infectious Diseases in Ancient China20240 iqtibos
6. Lunasin: Exploring the pharmacological potential of a soy-derived peptide20250 iqtibos
7. Association of platelet to albumin ratio with metabolic dysfunction-associated steatotic liver disease based on the National Health and Nutrition Survey 2017–201820250 iqtibos
8. IGFBP3-mediated effects of an effective combination therapy on HCC20250 iqtibos
9. Antiviral treatment for viral pneumonia: current drugs and natural compounds20250 iqtibos
10. Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems20250 iqtibos

Hammualliflar

1. Erkin Musabaev14 ta umumiy asar2024–2026
2. Khrystyna Pronyuk10 ta umumiy asar2024–2025
3. Yiping Dang7 ta umumiy asar2024–2026
4. Nguyễn Thị Thu Hiền7 ta umumiy asar2024–2025
5. Miao Luo4 ta umumiy asar2024–2026
6. Hao Zhang2 ta umumiy asar2025–2026
7. Huan Wang2 ta umumiy asar2024–2025
8. Guozhi Wu2 ta umumiy asar2024–2025
9. Chengyi He2 ta umumiy asar2025
10. Yunfei Chen2 ta umumiy asar2024–2025

Barcha hammualliflar →